Work

Prescription Drugs Subject to a Risk Evaluation and Mitigation Strategy: Patient Perspectives on Risk Communication and the Value of Educational Materials

Year: 2025

Type: article

Source: Drug Safety

DOI: 10.1007/s40264-025-01636-4

Authors: Susan Chimonas, Carol Cosenza, Aaron S. Kesselheim, Gita A. Toyserkani, Kate Heinrich Oswell, Cynthia LaCivita, Gerald J. Dal Pan, Ameet Sarpatwari

Institutions: Memorial Sloan Kettering Cancer Center, University of Massachusetts Boston, Brigham and Women's Hospital, Harvard University, United States Food and Drug Administration, Center for Drug Evaluation and Research

Language: English

Topic: Patient-Provider Communication in Healthcare

Subfield: General Health Professions

Field: Health Professions

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Massachusetts General Hospital, University of Massachusetts Boston, National Institutes of Health, U.S. Food and Drug Administration, National Cancer Institute, Center for Drug Evaluation and Research

Awards: G2746318747, G3050811832, G7237167005, Cancer Center Support Grant

OpenAlex ID: W4416735297

FWCI: 2.504

Cites: 25

Cited by: 2

Related to: 10